Center for Neuroscience and Pain Research, Department of Anesthesiology and Perioperative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030.
J Neurosci. 2024 Jul 17;44(29):e0392242024. doi: 10.1523/JNEUROSCI.0392-24.2024.
Calcineurin inhibitors, such as cyclosporine and tacrolimus (FK506), are commonly used immunosuppressants for preserving transplanted organs and tissues. However, these drugs can cause severe and persistent pain. GluA2-lacking, calcium-permeable AMPA receptors (CP-AMPARs) are implicated in various neurological disorders, including neuropathic pain. It is unclear whether and how constitutive calcineurin, a Ca/calmodulin protein phosphatase, controls synaptic CP-AMPARs. In this study, we found that blocking CP-AMPARs with IEM-1460 markedly reduced the amplitude of AMPAR-EPSCs in excitatory neurons expressing vesicular glutamate transporter-2 (VGluT2), but not in inhibitory neurons expressing vesicular GABA transporter, in the spinal cord of FK506-treated male and female mice. FK506 treatment also caused an inward rectification in the current-voltage relationship of AMPAR-EPSCs specifically in VGluT2 neurons. Intrathecal injection of IEM-1460 rapidly alleviated pain hypersensitivity in FK506-treated mice. Furthermore, FK506 treatment substantially increased physical interaction of α2δ-1 with GluA1 and GluA2 in the spinal cord and reduced GluA1/GluA2 heteromers in endoplasmic reticulum-enriched fractions of spinal cords. Correspondingly, inhibiting α2δ-1 with pregabalin, genetic knock-out, or disrupting α2δ-1-AMPAR interactions with an α2δ-1 C terminus peptide reversed inward rectification of AMPAR-EPSCs in spinal VGluT2 neurons caused by FK506 treatment. In addition, CK2 inhibition reversed FK506 treatment-induced pain hypersensitivity, α2δ-1 interactions with GluA1 and GluA2, and inward rectification of AMPAR-EPSCs in spinal VGluT2 neurons. Thus, the increased prevalence of synaptic CP-AMPARs in spinal excitatory neurons plays a major role in calcineurin inhibitor-induced pain hypersensitivity. Calcineurin and CK2 antagonistically regulate postsynaptic CP-AMPARs through α2δ-1-mediated GluA1/GluA2 heteromeric assembly in the spinal dorsal horn.
钙调神经磷酸酶抑制剂,如环孢素和他克莫司(FK506),通常被用作移植器官和组织的免疫抑制剂。然而,这些药物会引起严重且持续的疼痛。GluA2 缺失、钙通透性 AMPA 受体(CP-AMPAR)与多种神经疾病有关,包括神经性疼痛。目前尚不清楚组成型钙调神经磷酸酶(一种 Ca/钙调蛋白蛋白磷酸酶)是否以及如何控制突触 CP-AMPAR。在这项研究中,我们发现用 IEM-1460 阻断 CP-AMPAR 可显著降低 FK506 处理的雄性和雌性小鼠脊髓中表达囊泡谷氨酸转运体-2(VGluT2)的兴奋性神经元中 AMPAR-EPSC 的振幅,但对表达囊泡 GABA 转运体的抑制性神经元无影响。FK506 处理还导致 AMPAR-EPSC 的电流-电压关系产生内向整流,这种内向整流仅在 VGluT2 神经元中出现。鞘内注射 IEM-1460 可迅速缓解 FK506 处理小鼠的痛觉过敏。此外,FK506 处理可显著增加脊髓中 α2δ-1 与 GluA1 和 GluA2 的物理相互作用,并减少富含内质网的脊髓中 GluA1/GluA2 异源二聚体。相应地,用普瑞巴林、基因敲除或用 α2δ-1 C 端肽破坏 α2δ-1-AMPAR 相互作用抑制 α2δ-1,可逆转 FK506 处理引起的脊髓 VGluT2 神经元中 AMPAR-EPSC 的内向整流。此外,CK2 抑制可逆转 FK506 处理引起的痛觉过敏、α2δ-1 与 GluA1 和 GluA2 的相互作用以及脊髓 VGluT2 神经元中 AMPAR-EPSC 的内向整流。因此,脊髓兴奋性神经元中突触 CP-AMPAR 的增加在钙调神经磷酸酶抑制剂引起的痛觉过敏中起主要作用。钙调神经磷酸酶和 CK2 通过 α2δ-1 介导的 GluA1/GluA2 异源二聚体组装在脊髓背角拮抗调节突触后 CP-AMPAR。